Xiu‐Da Shen, Feng Gao, Bibo Ke, Yuan Zhai, Charles R. Lassman, Sei‐Ichiro Tsuchihashi, Douglas G. Farmer, Ronald W. Busuttil, Jerzy W. Kupiec‐Weglinski – 23 September 2005 – The current models of liver ischemia/reperfusion injury (IRI) in mice are largely limited to a warm ischemic component. To investigate the mechanism of hepatic “cold” IRI, we developed and validated a new mouse model of prolonged cold preservation followed by syngeneic orthotopic liver transplantation (OLT).

Mark W. Russo, Roberto J. Firpi, David R. Nelson, Robert Schoonhoven, Roshan Shrestha, Michael W. Fried – 23 September 2005 – Recurrent hepatitis C after liver transplantation is a serious problem faced by liver transplant recipients. Activation of hepatic stellate cells is an early step in hepatic fibrogenesis. The aim of this study was to evaluate hepatic stellate cell activation, early after liver transplantation, as a predictor for the subsequent development of advanced fibrosis.

New York State Department of Health Workgroup – 23 September 2005

23 September 2005

Shin Hwang, Sung‐Gyu Lee, Jae‐Won Joh, Kyung‐Suk Suh, Dong‐Goo Kim – 23 September 2005 – Current selection criteria of liver transplantation (LT) for patients with hepatocellular carcinoma (HCC) were derived from the outcomes of cadaveric donor LT (CDLT). We tried to assess the applicability of such criteria to living donor LT (LDLT) through a comparative study between CDLT and LDLT. We analyzed the outcomes of 312 HCC patients who underwent LT at 4 Korean institutions during 1992 to 2002.

Pietro Majno, Gilles Mentha, Vincenzo Mazzaferro – 23 September 2005

John Fung, Jorge Rakela – 23 September 2005

Shimon Kusne, Jerry Smilack – 23 September 2005

Neal R. Barshes, Timothy C. Lee, Rajesh Balkrishnan, Saul J. Karpen, Beth A. Carter, John A. Goss – 23 September 2005 – Biliary atresia is the most common indication for orthotopic liver transplantation (OLT) in the pediatric population. The outcomes of liver transplantation for biliary atresia, however, have not been formally examined on a national scale. The objective of this study was to identify pretransplant variables that predict patient survival after primary liver transplantation for biliary atresia.

Peter L. Abt, Ibrahim Abdullah, Kathleen Korenda, Adam Frank, Heather Peterman, G. Robert Stephenson, James F. Markmann, Abraham Shaked, Kim M. Olthoff – 23 September 2005 – Appendicitis among liver transplant recipients has not been described in the current literature. We report 8 recipients who experienced appendicitis three weeks to 181 months after liver transplantation (LT). Initial presenting findings differed from the nonimmunosuppressed population in that a majority of the patients did not have leukocytosis (>10,000 cells/mm3).